Announced Thu, 18 Jun · 14:49 IST
Bacil Pharma to set up wholly-owned subsidiary
Strategic Transactions View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+3.8%1-day move
₹40.00
prior close
₹39.98
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-0.7-0.7+2.0+3.8-0.3+0.9+4.6-0.6-1.0-3.7-13.5——
Up moveDown movePending
AI summary
Bacil Pharma Ltd has informed the stock exchanges about its plan to incorporate a new wholly-owned subsidiary. The company has not yet disclosed the name, capital structure, or business activity of the proposed entity. Further details are awaited.
Likely market impact
Routine corporate action; limited immediate impact on shareholders until subsidiary details are shared.